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Abstract
Evidence-based dentistry is a critical evaluation, awareness of the available evidence to improve decision mak-
ing about the care of individual patients and / or communities. Objective: To systematically analyze the available 
scientific literature on clinical and radiographic results of two materials used in pulpotomy in primary teeth: for-
mocresol and mineral trioxide aggregate. Materials and methods: It was identified relevant publications through a 
search of electronic databases such as MEDLINE (Ovid) and The Cochrane Library. To be included in the review, 
studies had to define the material used in child patients with pulp exposure by caries or tooth-alveolar trauma. 
Results: Of the 21 articles obtained in the initial phase of the review, only 19 were available in full text and of these 
only met the requirements for inclusion 6 items, which were confronted, analyzed and discussed later. Conclu-
sions: The clinical evidence available showed significant differences regarding the use of a material or another. In 
addition to the findings of clinical follow - radiographic and taking into account the potential toxicity of formocre-
sol suggest the use of mineral trioxide aggregate pulpotomy of primary teeth.
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Introduction
The progress in understanding of molecular and cellular 
changes during dental development and how are they 
imitated during tissue repair, offers the opportunity of 
evaluating the biological validity of different strategies 
in vital pulp therapy.   Under this perspective, and based 
on a good clinical history to arrive at a proper diag-
nosis, different pulp therapy options, such as indirect 
pulp treatment (IPT), direct pulp treatment (DPT), pul-
potomy and pulpectomy are available (1). 
If a tooth with a carious lesion remains untreated or, is 
inadequately treated, a bacterial invasion of the coronal 
pulp will occur originating an inflammatory response at 
that level.  In this stage the inflammation is confined to 
this space, but if the affected tissue is removed and the 
entrance to the root canals is covered with an appropri-
ate agent, the remaining tissue is capable of recovering. 
This capability is used when a molar with a pulp expo-
sure is treated with vital pulp therapy. In this manner, 
the main objective of pulp treatment is to preserve the 
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integrity and health of oral tissues. However, if a tooth 
can continue functioning without vital coronal pulp; it is 
desirable to preserve pulp vitality; therefore, the objec-
tive of vital pulpotomy is to treat reversible injury (2). 
Pulpotomy is one the most frequently used treatments 
to maintain primary molars with carious involvement, 
symptomless or with reversible pulpitis which other-
wise would be extracted. Its objective is to preserve 
radicular pulp, avoid pain, inflammation and, maintain 
the tooth (3). 
Formocresol (FC) was first used in 1930 by Sweet who 
reported a success rate of 97%. It produces an area of 
necrosis adjacent to the lesion. The tissue is often al-
tered by formaldehyde and appears “fixed” in situ and 
therefore is not subjected to liquefaction necrosis in 
the root canal. It is the most frequently used pulp cap-
ping agent in deciduous molars, however, formaldehyde 
which is the most important component of formocre-
sol, shows certain risk of systemic distribution after its 
use (4).  Several concerns have been expressed recently 
with respect to the use of formocresol in pulpotomies 
because of the  following: pulp response with inflamma-
tion and necrosis, citotoxicity, systemic disturbances, 
possible mutagenicity and carcinogenicity and altered 
immune response. 
However with the advance of technology, different com-
pounds are being studied in order to find one that pro-
vides better clinical efficacy without secondary effects, 
among them, the following have been widely reported 
in the scientific literature: electro surgery, Er:YAG laser, 
calcium hydroxide, glutaraldehide, ferric sulfate, colla-
gen enriched solution, bone morphogenetic proteins or 
mineral trioxide aggregate (M.T.A.) (3).
The objective of this systematic review of the literature 
is to compare the available evidence on the clinical and 
radiographic effects of formocresol with mineral triox-
ide aggregate in deciduous molars treated with pulpo-
tomy. 
Materials and Methods
A computarized search of the literature was done us-
ing MEDLINE (Ovid: 1960-2008) (Table 1), and The 
Cochrane Library. Randomized controlled trials which 
compared formocresol and/or mineral trioxide aggre-
gate pulpotomies in primary teeth, were selected. The 
titles and abstracts of the studies were evaluated accord-
ing to relevance after obtaining the full text articles. 
The search ended in January 2009. 
The inclusion criteria were: studies that evaluated pulp 
treatment of primary molars with vital pulp exposure 
due to caries or trauma which included drugs such as 
formocresol and/or mineral trioxide aggregate, follow 
up time of at least 6 months, symptomless teeth without 
indication of irreversible pulpitis, restorable teeth, and 
evaluation by clinical and radiographic methods.  Exclu-
sion criteria: lack of randomization of the subjects, ani-
mal or in vitro studies, absence of comparison between 
the treatment groups, the article could not be found. 
Initially we found 21 articles for possible inclusion, 
when the criteria were applied, 6 articles (randomized 
controlled clinical trials) were selected for further anal-
ysis (Table 2).  
KEYWORDS RESULTS
1 Pulpotomy 296
2 Pulp therapy 179
3 Primary molar 290
4 Formocresol 117
8 1 and 3 65
9 1 or 3 521
10 4 and 1 and 3 41
11 4 or 1 or 3 567
12 FC 21668
13 8 and 9 and 10 and 11 and 12 21
 AGE
TREATED 
MOLARS
CLINICAL 
OUTCOMES
RADIOGRAPHIC 
OUTCOMES TIME
St. SIG-
NIF.
ARTICLE YEARS FC MTA FC MTA FC MTA MONTHS p
Agamy et al, 2004. 6.1 20 20 18(90) 19(100*) 18(90) 19(100) 12 > 0.05
Holan et al, 2005. 6.2 29 33 24(83) 32(97) 24(83) 32(97) ≤ 74 > 0.05
Farsi et al, 2005. 6.0 36 38 35(97.2) 38(100) 31(86.8) 38(100) 24 0.03
Naik y Hedge, 2005. N.E. 23 24 23(100) 24(100) 23(100) 24(100) 6 N.A
Aienehchi et al, 2005 6.4 57 43 57(100) 43(100) 47(90.5) 43(100) 6 0.03
Noorollahian et al, 2008 6.0 27 29 18(66) 18(66) 18(62) 17(58) 24 > 0.05
Table 2. Evidence that compare formocresol (FC) vs mineral trioxide aggregate (MTA) pulpotomy outcomes. 
Treated molars:  molar teeth treated in each technique. Clinical outcomes: frequency of clinical success. Radiographic outcomes: frequency 
of radiographic success. Time (Months): follow-up months. St Signif: statistical significance of the outcomes represented by the “p-value”.
Parentheses: success rate of each material. *One exfoliated molar, for this reason, authors consider 100% success.
Table 1. Search strategy in MedLine (Ovid). FC: Formocresol. 
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Afterwards, the articles were indexed in a digital data 
base and each one was evaluated taking as reference 
data, the authors, title, journal, year, volume, number, 
month and, pages. The methodology used was detailed 
and emphasis was also placed on the results (number of 
teeth, success rate, failure rate, frequencies). The results 
were confronted and analyzed to be discussed later. 
Results and Discussion
Formocresol was first introduced in 1904 (5) by Buck-
ley; since then it is considered as the “gold standard” 
with which other drugs must be compared in pulpotomy 
experiments in primary molars. It became the most 
widely used drug due to its bacteriostatic and fixative 
properties, with a success rate varying from 55% to 98%. 
However, other authors suggest that the clinical and ra-
diographic efficacy of formocresol varies between 70 
to 97% (6). Its chemical composition of formaldehyde 
(mutagenic and carcinogenic) and cresol (caustic agent), 
elicits concerns, even though there is no evidence that 
its systemic distribution can cause disease (7).
The histological response of the pulp after formocresol 
treatment seems to be unfavorable. Several researchers 
have reported that after application of formocresol, there 
is fixation of the coronal third in the radicular pulp and 
chronic inflammation in the middle third, leaving the 
apical third unaltered or vital. Other authors report that 
the remaining pulp tissue is partially or totally necrotic. 
Frequently, the pulp remains half vital, half necrotic and 
chronically inflamed. Although many studies published 
in the 90’s questioned the safety and efficacy of formo-
cresol, different researchers agree that it is potentially 
mutagenic but still is the drug of choice for pulpotomies 
in the deciduous dentition. 
However, the International Agency for Research on 
Cancer (IARC), evaluating the available literature, 
concluded that there is sufficient evidence, in animal 
and human experimentation, to classify formaldehyde 
as carcinogenic. IARC recommended the substitution 
of formaldehyde containing materials for safer alterna-
tives (8). 
In spite the efforts the scientists are doing searching for 
an adequate replacement material for FC, the studies 
on a new material called Mineral Trioxide Aggregate 
(M.T.A.), developed by Torabinejad et al (9) at Loma 
Linda University (Loma Linda University, CA, USA) 
suggest excellent results when is used for pulpotomies 
in primary teeth. 
It was only in 1998, that the Food and Drug Administra-
tion of the United States approved M.T.A as a therapeu-
tic endodontic material for human use (10). M.T.A is a 
powder consisting of tricalcium silicate, bismuth oxide, 
dicalcium silicate, tetracalcium aluminate, tetracalcium 
aluminate ferrate and dehydrated calcium sulphate. 
Histological studies by Torabinejad et al (11) used MTA 
to repair endodontic perforations; the material showed 
biocompatibility and very little inflammation, even 
when the material extruded from the perforation site. 
Recently, MTA was introduced as a potential alternative 
agent to formocresol with characteristics of liberation 
of cytokins from the bone cells, induction of hard tissue 
formation, odontogenic effect on the pulp, antimicrobial 
properties and preservation of pulp integrity after pulp 
capping or pulpotomy, without citotoxic effects (12).  
Agamy et al in 2004 (13), in a randomized controlled 
study, selected 72 molars in 24 children for clinical and 
radiographic study. The selected teeth were randomly 
assigned and divided in to three groups according to 
the pulp filling material used (Gray MTA, White MTA 
or formocresol).  An additional group of 15 teeth was 
prepared for serial extraction in order to carry out his-
tological evaluation. The pulpotomies were performed 
by the same operator and the results evaluated by two 
pediatric dentists who did not know which tooth had 
which material was being evaluated (blind study). 
The results showed that all 60 teeth were considered 
clinically and radiographically successfully at the first 
month of postoperative evaluation. At three months, a 
tooth from the white M.T.A. group was diagnosed as a 
clinical and radiographic failure due to an abscess, and 
was extracted. The 59 remaining teeth were considered 
as clinically and radiographically successful at the 3 
month postoperative evaluation. At 6 months, a tooth 
from the Gray M.T.A. groups was lost due to exfoliation 
and the remaining 58 teeth were diagnosed as clinically 
and radiographically successful. At the 12 month evalu-
ation, the 19 teeth from the Gray M.T.A. group were 
all considered clinically and radiographically success-
ful.  In the White M.T.A. group, 3 teeth were diagnosed 
as clinical and radiographic failures. The 16 remaining 
teeth in the Gray M.T.A. group were evaluated as clini-
cal and radiographic success. Two teeth in the formocre-
sol group were diagnosed as clinical and radiographic 
failures. When statistical tests were applied, there were 
no statistical significant differences between one mate-
rial and the other.    
Farsi et al in 2005 (14) in a randomized controlled trial, 
compared the clinical and radiographic results of pri-
mary molars treated formocresol pulpotomy or MTA 
pulpotomy; they selected a randomized sample of 100 
children for the study. A total of 120 teeth were included 
and the coronal pulp was amputated using a convention-
al pulpotomy technique. All the groups were treated un-
der the same protocol, except for the application of the 
material. The teeth were divided in two equal groups, 
one group received MTA as filling material and FC was 
used in the other group. 
Their results showed that of the 120 treated teeth, only 
74 were available for clinical and radiographic evalua-
tion through the follow up period (24 months). During 
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the first 12 months there were no clinical or radiograph-
ic pathologies in either group. Radiographic pathology 
was evident in 4 cases of the 38 (10.51%) patients treat-
ed with FC; on the other hand, there were no evident 
clinical symptoms of failure in this stage.  Of the cases 
reported as failures, 3 teeth revealed internal resorption 
and one tooth showed furcation involvement. 
After twelve months the results indicated that none of the 
MTA treated teeth presented evidence of radiographic 
pathology or clinical signs of failure.  The difference, 
however, was not statistically significant (p=0.64). After 
twelve months, the FC group showed 5 cases of pulpal 
pathology (13.2%), with only one case of pain. All of the 
reported failures showed internal resorption and, two 
of them revealed furcation involvement. On the other 
hand, all of the 38 MTA treated teeth were considered 
as clinically and radiographically successful. The statis-
tical difference between the two groups after 24 months 
of evaluation was evident as it regards to radiographic 
pathology (p=0.031).
Holan et al in 2005 (15) in a comparative study of for-
mocresol versus MTA pulpotomies, selected a total of 
64 primary molars which received pulpotomies from a 
sample of 35 children randomly assigned by the toss of 
a coin to either one of the two groups. In case one of the 
children had two molars needing pulpotomies, the other 
molar was assigned to the alternative group. If a child 
needed 3 pulpotomies, the capping material was again 
decided by the toss of a coin. The children came back 
for re evaluation every 6 months for a total average of 
38 months. 
Their results revealed that of the 64 molars treated, 62 
teeth in 33 children were available for evaluation of suc-
cess/failure rate. Two molars in two patients, both from 
the FC group were excluded from the study because the 
patients never returned for the follow up visits. The cap-
ping material used was MTA in 33 molars and FC in 
29 molars. The failures were detected in 6 teeth after 
an average follow up period of 16 months. Twenty nine 
teeth with successful treatment were followed until their 
normal exfoliation with an average follow up period of 
33 months. The remaining 27 successfully treated teeth 
had an average follow up period of 49 months with no 
difference between the experimental and the control 
group. 
The success rate of pulpotomies in all the teeth for this 
study was 90%. MTA was successful in 97% (32/33) 
and FC was successful in 83% (24/29) without statis-
tical significant difference between the two materials. 
The follow up evaluation revealed 6 failures (10%): 5 of 
them in the FC group and 1 in the MTA group.  
The most common radiographic finding among all teeth 
was obliteration of the root canals 55% (34/62). It was 
found in 58% of the MTA treated teeth (19/33) and in 
52% (15/29) of the FC treated teeth, followed by internal 
resorption which was observed in 8 teeth (6 with FC and 
2 with MTA). The least frequent finding was a dentinal 
bridge which was detected on tooth treated with MTA. 
Naik and Hedge in 2005 (16) in a randomized con-
trolled trial included 50 symptomless primary molars 
with deep carious lesions and randomly assigned for 
treatment with FC or with MTA (25 teeth per group). 
All teeth were restored with stainless steel crowns and 
clinical and radiographic controls were done during 6 
months (Controls at 1-3-6 months).  
The results revealed that of the 50 teeth selected, 3 were 
not available for follow up after the first month. The 
follow up appointments after the first, third and sixth 
months did not show any clinical or radiographic patho-
logical findings on the rest of the 47 teeth, therefore, no 
statistical analysis was carried out due to the success 
of the treatment. The only significant finding was color 
change in 60% of the teeth in which MTA was the medi-
cament used after 24 hours, but was later masked when 
the stainless steel crown was placed. 
Peng et al in 2006 (17) did a review of the literature ap-
plying the meta analysis technique and compared FC 
and MTA through six articles evaluated by means of 
the Jadad scale and found that there was a statistically 
significant difference between the success rates of FC 
and MTA in molars treated with pulpotomy. The clini-
cal and radiographical evaluations indicated that MTA 
was superior to FC with a lower failure rate. They con-
cluded that MTA induced a less undesirable response 
and could be a good substitute for pulpotomies in pri-
mary teeth. 
Aeinehchi et al in 2007 (18) in a randomized controlled 
study compared the effects of MTA and FC in primary 
molars treated with pulpotomy. 126 children between 
the 5 and 9 years of age and who required pulpotomy, 
were selected. The patients were assigned by a random 
number automatically originating the control or the ex-
perimental group. A total of 75 patients were assigned 
to the formocresol group and 51 to the MTA group. Of 
the 126 patients, 26 did not return for the follow up ap-
pointments (18 FC and 8 MTA), resulting in 100 cases 
for analysis. At three months of follow up there were no 
signs of failure in neither of the groups. A radiographic 
evaluation of the teeth revealed root resorption in one 
of the 57 cases in the FC group. This finding was not 
observed in the MTA group. After 6 months of follow 
up there was no clinical failure, however in 6 of the 57 
cases treated with FC, root resorption was observed and 
in 4 of the cases the periodontal tissues were affected. 
The MTA group did not present such characteristics. 
The differences between the groups were statistically 
significant. 
Noorollahian et al in 2008 (19) in a randomized con-
trolled clinical study compared the results of MTA ver-
sus FC in pulpotomized primary teeth in 46 children 
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between the ages of 5 and 7 years. Sixty lower second 
primary molars received pulpotomy treatment (FC - 
MTA). The teeth were randomly assigned to the control 
or to the experimental group (30 teeth each) using a ran-
dom table. The data was analyzed during 24 months to 
evaluate the success rate during the different follow up 
periods (6, 12, and 24 months).
Their findings indicate that at 6 months of follow up, 
43 children with a total of 56 teeth, returned for post-
operative control. All the teeth treated in both groups 
(FC=27- MTA=29) were clinically and radiographically 
successful. At the 12 month follow up visit, 43 children 
with 53 teeth were available for clinical and radiograph-
ic evaluation. The formocresol treated teeth (27) were 
clinically and radiographically successful. The MTA 
treated teeth (29) were clinically successful but the 
radiographic examination revealed one failure, which 
consisted of furcation involvement.    At the 24 month 
follow up 27 children with 36 teeth were available for 
postoperative control. The formocresol (18) treated 
teeth were clinically and radiographically successful. 
The MTA (18) treated teeth were clinically successful. 
The radiographic follow up revealed one failure, furca-
tion involvement, in another one of the molars treated 
with MTA. Obliteration of the pulp canals observed in 
1 of the MTA treated teeth and in 4 of the formocresol 
treated teeth. 
Conclusions
The present available literature is an important tool for 
rationalizing correct clinical decisions. This is why the 
scientific efforts to improve do not stop and include new 
concepts and treatment strategies in order to reduce the 
incidence of adverse effects and increase their biocom-
patibility.   
Based on the scientific evidence found until now, hu-
man primary molars with reversible pulpitis, with pulp 
exposure due to caries or to dentoalveolar trauma, can 
be treated with formocresol or mineral trioxide ag-
gregate, with similar success rates but with significant 
differences as is evidenced by a recent meta-analysis. 
Considering the frequency of appearance of radio-
graphic findings, such as furcation involvement, and its 
questionable citotoxicity, as it regards to the use of for-
mocresol, the authors suggest the application of mineral 
trioxide aggregate.  
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